Search Results for “EC” – Page 537 – media

MiMedx shares falls by 20%

The US-Based MiMedx group's (a manufacturer of regenerative medicine) shares fell 20% after the federal prosecutors charged three healthcare professional for accepting bribes from Mimedx. Of these shares, 7.5% recovered when closing for the day.
- Source: drugdu
- 488
- May 10, 2018
Company Insights
Funds of £1.5 million raised by UK-based life sciences group

With a view to augment business activities and help improve product outreach; a UK-based life sciences firm has raised £1.5 million.
- Source: drugdu
- 814
- May 10, 2018
antibody Company Insights
Lynparza tablets (ovarian cancer) given go-ahead by European regulators

With a view to widening the scope of treatment for ovarian cancer patients, EU regulators have greenlighted MSD’s Lynparza and stamped approval for a new dosing regimen and tablet formulation for AstraZeneca.
- Source: drugdu
- 743
- May 10, 2018
AstraZeneca cancer New Approvals pharma
Johnson & Johnson’s Darzalex snags landmark myeloma approval in first-line patients

EHR vendor Allscripts has made an agreement to purchase patient communication app maker Health Grid for $60 million in cash, with an additional $50 million in earnout payments based on Health Grid achieving certain revenue targets over the next three years, according to a recently registered SEC filing. The merger of the two companies is expected to close sometime during Q2 2018.
- Source: fiercepharma
- 571
- May 10, 2018
Darzalex Johnson & Johnson myeloma
World’s first Train Hospital helping rural Indian population

The Lifeline Express was introduced to meet two gaps: giving medical treatment in the remotest villages and providing lower-income people with free treatment. The train runs all over India, reaching the remotest places and halting in one place for a month before proceeding.
- Source: Ddu
- 634
- May 9, 2018
healthcare India Researches
NHS England moves to fast-track clinical trials

NHS England has unveiled new processes designed to fast track clinical trials undertaken across the NHS, and boost access for patients.
- Source: pharmatimes
- 601
- May 9, 2018
Clinical Trials NHS
Takeda, Japanese pharma giant clinched to Buy Shire for $61.50 billion

On Monday Takeda Pharmaceutical confirmed to acquire Shire for £45.3 billion ($61.50 billion). The final deal will be 46 percent cash and 54 percent stock.
- Source: business standard
- 674
- May 9, 2018
Market Views merger-and-acquisition Shire Takeda
Appointment booking app Solv Health raised $16.8 million

San Francisco-based appointment booking application Solv Health announced that it has raised $16.8 million in Series B funding from Greylock Partners, along with Benchmark and Aspect Ventures. The company also unveiled its new Solv Pay feature, which helps to make payment quicker and easier for its users.
- Source: drugdu
- 709
- May 9, 2018
Company Insights digital health healthcare
Boosted by China launch, Merck’s Gardasil turns in a big first-quarter performance

Merck generated more than $1.5 billion in first-quarter vaccine sales. (Merck)
- Source: fiercepharma
- 578
- May 9, 2018
Gardasil HPV vaccine Merck
Mobile-Health applications and wearables, to improve medication Adherence

Consumers are depending on mHealth applications and wearable devices to improve their medication abidance.
- Source: Ddu
- 781
- May 8, 2018
digital health Market Views mHealth

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.